Trial · NCT02449291
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Complete Response (Success of Initial PONV Treatment) | APD421 5mg IV | 60 | Participants | ||
| Complete Response (Success of Initial PONV Treatment) | APD421 10mg IV | 59 | Participants | ||
| Complete Response (Success of Initial PONV Treatment) | Placebo | 39 | Participants | ||
| Number of Participants With Complete Response 0-2 Hrs | APD421 5mg | 112 | Participants | ||
| Number of Participants With Complete Response 0-2 Hrs | APD421 10mg | 105 | Participants | ||
| Number of Participants With Complete Response 0-2 Hrs | Placebo | 79 | Participants | ||
| Number of Participants With Complete Response 2-24 Hrs | APD421 5mg | 100 | Participants | ||
| Number of Participants With Complete Response 2-24 Hrs | APD421 10mg | 109 | Participants | ||
| Number of Participants With Complete Response 2-24 Hrs | Placebo | 96 | Participants | ||
| Time to Treatment Failure | APD421 5mg | 159 | Inter-Quartile Range 68 to NA | minutes | |
| Time to Treatment Failure | APD421 10mg | 177 | Inter-Quartile Range 53.5 to NA | minutes | |
| Time to Treatment Failure | Placebo | 79 | Inter-Quartile Range 34 to 383 | minutes | |
| Number of Patients Experiencing Incidence of Emesis | APD421 5mg | 64 | Participants | ||
| Number of Patients Experiencing Incidence of Emesis | APD421 10mg | 57 | Participants | ||
| Number of Patients Experiencing Incidence of Emesis | Placebo | 62 | Participants | ||
| Number of Participants Using Rescue Medication | APD421 5mg | 121 | Participants | ||
| Number of Participants Using Rescue Medication | APD421 10mg | 119 | Participants | ||
| Number of Participants Using Rescue Medication | Placebo | 135 | Participants | ||
| Incidence of Significant Nausea | APD421 5mg | 114 | Participants | ||
| Incidence of Significant Nausea | APD421 10mg | 108 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02449291/results